Posted in | News | Materials Research | Biomaterials | Building and Construction

$15million Second Round Funding for Finnish Biomaterials Company

Jun 6 2002

Finnish biomaterials company Inion have secured $15 million in series B funding. The main contributors were Healthcap, Capman AB and POD Holdings all of Sweden. First round financiers Bio Fund of Finland and Bank von Ernst of Switzerland along with other Finnish institutions also participated in the second round funding.

The new involvement brings financial acumen and business development potential to the table as well funding. The new funding will be used to continue building of their global marketing infrastructure including direct sales forces in Europe and the USA.

The new funding will also enable them to focus on their next area of products, orthopaedics. In this area they will accelerate research into bioactive materials for use in second generation hybrid products.

For more information on biomaterials click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback